PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Total Current Liabilities | ₹4,457 Cr | ₹3,851 Cr | ₹3,118 Cr | ₹2,591 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹4,457 Cr |
Mar2023 | ₹3,851 Cr |
Mar2022 | ₹3,118 Cr |
Mar2021 | ₹2,591 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4,457 Cr | 15.74 | |
Mar2023 | ₹3,851 Cr | 23.51 | |
Mar2022 | ₹3,118 Cr | 20.35 | |
Mar2021 | ₹2,591 Cr | - |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹27,374.9 Cr | 0.4% | -0.4% | 39.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -2% | -8.4% | 14.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,673.0 Cr | -0.2% | 7.5% | 48% | Stock Analytics | |
CIPLA | ₹118,908.0 Cr | -0.3% | -2.6% | 0.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,106.0 Cr | -1% | -4.1% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,494.0 Cr | 0.3% | 8% | 6.2% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 0.4% |
-0.4% |
39.9% |
SENSEX | -0.4% |
0.3% |
8.7% |
You may also like the below Video Courses